Mark Maciejewski is a senior-level investment professional and entrepreneur based in Hong Kong, specializing in life science investing and venture capital. Mark has directed SHANGHAI Biomedical Enterprise LLC since 2010, incubating disruptive medical technology companies in China, and serves as a board member at TruTag Technologies. Previously, Mark has held leadership positions including President & CEO at Sinnomedical LLC and Angioguard, alongside senior roles at Boston Scientific and the National Investment Authority. Mark holds multiple advanced degrees, including an MBA from the University of St. Thomas and a Master of Science in Biochemistry from Wright State University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices